“We’re not really sure what the state of all of that will be after this, but I think as of now, we’re going to try and find a place to live, and then hopefully everything else will fall into place somehow.”

The lawsuit said despite Sommer’s dismissal of the case and her harsh criticism of the conduct of the local prosecutor and sheriff’s deputies, “this action is necessary to vindicate Baldwin’s rights and deter Defendants from attempt to do this to anyone else.”

But how much attention did you pay to what else had been going on in the world over the past seven days?

If nothing else, it’s pretty bad news when Congress writes a law with your company’s name in it.

Recursion co-founder and CEO Chris Gibson says what matters most in the field is something neither Recursion nor anyone else has yet shown: that these AI-discovered molecules can make it through clinical trials and that, over time, they deliver an increased probability of success over traditional methods.